100 Participants NeededMy employer runs this trial

Insulin for Insulin Resistance

LN
Overseen ByLuke Norton, Ph.D
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas Health Science Center at San Antonio
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

In this study, the investigators will use euglycemic/hyperinsulinemic clamps, longitudinal skeletal muscle biopsies, and single nucleus ribonucleic acid sequencing (RNA-Seq) and assay for transposase-accessible chromatin using sequencing (ATAC- seq) to reveal cell type-specific molecular response quantitative trait loci (rQTLs) acutely regulated by insulin signaling and glucose uptake.

Who Is on the Research Team?

LN

Luke Norton, PhD

Principal Investigator

The University of Texas Health Science Center at San Antonio

Are You a Good Fit for This Trial?

This trial is for adults who are being studied for how their muscles respond to insulin. Specific inclusion and exclusion criteria are not listed, but generally participants should be healthy enough for muscle biopsies and insulin testing.

Inclusion Criteria

I am between 18 and 75 years old.
Body Mass Index (BMI) > 18
Normal glucose tolerance defined by fasting blood sugar < 100 mg/dL and 2-hour Oral Glucose Tolerance Test (OGTT) < 140 mg/dL
See 6 more

Exclusion Criteria

Partial thromboplastin time (PTT) > 35
International normalized ratio (INR) > 1.2
Urine albumin excretion > 300 mg/day
See 15 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants undergo euglycemic/hyperinsulinemic clamp procedures with skeletal muscle biopsies

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

1-2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Insulin 80mU/m2*min

Trial Overview

Researchers will give participants a controlled dose of insulin through an IV while keeping blood sugar steady, then take muscle samples to study genetic responses in the cells using advanced sequencing techniques.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Insulin stimulatedExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Health Science Center at San Antonio

Lead Sponsor

Trials
486
Recruited
92,500+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+